AM

Ashima Mahajan

Director Director DIN 07108641
DIN 07108641 First appointment Mar 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2015
Shareholding value Locked Premium profile

About Ashima Mahajan

Data last updated:

Ashima Mahajan has 11 years in corporate governance. Formerly with 1 company, such as Bark & Leef Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07108641
Primary Designation Director
First Appointment 03 Mar 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Bark & Leef Pharma Private Limited U24233UP2015PTC069305
Director03 Mar 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bark & Leef Pharma Private Limited
Premium access

Shareholding and investment profile for Ashima Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashima Mahajan

Ashima Mahajan has 11 years in corporate governance. Formerly with 1 company, such as Bark & Leef Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ashima Mahajan is associated with 0 companies as a director.

Ashima Mahajan has expertise in General Business.

Ashima Mahajan has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available